final program

 

Click here to download Final Program as a pdf.


Saturday,
July 27, 2013
Sunday,
July 28, 2013
Monday,
July 29, 2013
Oral Presentations Oral Presentations Oral Presentations
Poster Sessions Poster Sessions Poster Sessions

 

Saturday, July 27, 2013

09:00 - 10:15   HALL A
 09:00

OC OPENING CEREMONY
Chair:John A. Elefteriades, USA

GREETINGS
Asher Kimchi, USA
Founder and Chairman
International Academy of Cardiology

John A. Elefteriades, USA
Member, Scientific Executive Committee
Chairman, Section of Cardiovascular Surgery
International Academy of Cardiology

Jeffrey S. Borer, USA
Chairman, Scientific Executive Committee
Chairman, Section of Valvular Heart Disease
International Academy of Cardiology

Naranjan S. Dhalla, Canada
Member, Scientific Executive Committee
Chairman, Section of Cellular Biology of the Heart
International Academy of Cardiology

William Bommer, USA
Member, Scientific Executive Committee
International Academy of Cardiology

Stephen L. Kopecky, USA
Member, Scientific Executive Committee
International Academy of Cardiology


PRESENTATION OF 2013 AWARDS
John A. Elefteriades, USA
Jeffrey S. Borer, USA

 
09:40 - 10:15 OL OPENING LECTURE - SIXTH H.J.C. SWAN MEMORIAL LECTURE
Chair: N.D. Wong, Irvine, CA, USA

HALL A
09:40 INTRODUCTION
N.D. Wong, Irvine, CA, USA
 
09:45 CVD IN WOMEN: A FRESH PERSPECTIVE (Opening Lecture)
E.A. Amsterdam, University of California, Davis Medical Center, Sacramento, CA, USA
 292
10:15  COFFEE BREAK, VISIT POSTERS AND EXHIBITION  
     
SATURDAY, JULY 27, 2013
10:45-13:30   HALL A
 

PL01    Plenary Session:
DISEASE MECHANISMS LEADING TO CARDIOMYOPATHY AND HEART FAILURE
 

Chairs:
K. Chatterjee
, Iowa, IA, USA
N.S. Dhalla, Winnipeg, Canada

 
10:45 ADVANCES IN PATHOPHYSIOLOGY AND MANAGEMENT OF DIASTOLIC HEART FAILURE (Invited Lecture)
K. Chatterjee, University of Iowa, IA, USA
001
11:00 REVERSAL OF CARDIAC REMODELING IN HEART FAILURE BY- ADRENOCEPTOR BLOCKADE (Invited Lecture)
N.S. Dhalla, St. Boniface General Hospital Research Centre, Winnipeg, MN, Canada
 
002
11:15 AGING AND HEART FAILURE. UPDATE (Invited Lecture)
B.I. Jugdutt, University of Alberta and Hospitals, Edmonton, AB, Canada
 
003
11:30 MITOCHONDRIAL FISSION AND FUSION IN HEART FAILURE (Invited Lecture)
A.A. Knowlton, L. Chen, University of California, Davis, CA, USA
004
11:45 PERSONALIZED MEDICINE IN DILATED CARDIOMYOPATHY (Invited Lecture)
L. Mestroni, University of Colorado Cardiovascular Institute, Aurora, CO, USA
005
12:00 GENETIC EPIDEMIOLOGY OF LEFT VENTRICULAR HYPERTROPHY (Invited Lecture)
J.N. Bella, Bronx-Lebanon Hospital Center, Bronx, NY, USA
006
12:15 BLUNTED RESPONSES OF RENAL SYMPATHETIC NERVE ACTIVITY TO C-TYPE NATRIURETIC PEPTIDE IN THE PVN OF RATS WITH HEART FAILURE (Invited Lecture)
K.P. Patel, B. Xu, H. Zheng, University of Nebraska Medical Center, Omaha, NE, USA
007
12:30 TRANSCRIPTIONAL MECHANISMS LEADING TO DILATED CARDIOMYOPATHY IN THE ABSENCE OF HYPERTROPHY (Invited Lecture)
B.S. Tuana, University of Ottawa Heart Institute, Ottawa, Ontario, Canada
008
12:45 CPT1b DEFICIENCY IS BAD FOR THE HYPERTROPHIED HEART (Invited Lecture)
Q. Yang, University of Alabama at Birmingham, Birmingham, AL, USA
009
13:00 DELETION OF THE TRANSLATIONAL REPRESSORS EUKARYOTIC TRANSLATION INITIATION FACTOR 4E BINDING PROTEINS 1 AND 2 PROTECTS AGAINST PRESSURE OVERLOAD INDUCED HEART FAILURE (Invited Lecture)
Z. Lu, X. Hu, Y. Huang, X. Xu, P. Zhang, M. Peterson, V.A. Polunovsky, N. Sonenberg, R.J. Bache, P.B. Bitterman, Y. Chen
University of Minnesota, MN, USA
010
13:15 RESIDUAL MYOCARDIAL INJURY AND ATTENUATED PRODUCTION OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) IN PATIENTS WITH RECOVERED PERIPARTUM CARDIOMYOPATHY (PPCM) (Invited Lecture)
S. Goland, L. Zilberman, I. Bar, S. Schwarzenberg, S. Shimoni, J. George Kaplan Medical Center, Rehovot, Israel
011
13:30 LUNCH BREAK, VISIT POSTERS AND EXHIBITION  
SATURDAY, JULY 27, 2013
10:45-13:00   HALL B

 

PL02   Plenary Session:
CARDIOVASCULAR IMAGING FOR EVALUATION OF CARDIAC STRUCTURE AND FUNCTION

Chairs:
D.S. Berman, Los Angeles, CA, USA
N.C. Nanda, Birmingham, AL, USA

 

10:45 NEWER ASPECTS OF EVALUATING LV FUNCTION BY ECHOCARDIOGRAPH (Invited Lecture)
N.C. Nanda, University of Alabama at Birmingham, Birmingham, AL, USA
 
012
11:00 FLURPIRIDAZ F 18 PET VERSUS TC-99M SPECT FOR MYOCARDIAL PERFUSION IMAGING (Invited Lecture)
D.S. Berman, J. Maddahi, Cedars-Sinai Medical Center; Los Angeles, CA, USA
 
013
11:15 USEFULNESS OF OPTICAL COHERENCE TOMOGRAPHY IN DAILY CLINICAL PRACTICE (Invited Lecture)
T. Akasaka, T. Kubo, Y. Ino, T. Tanimoto, T. Yamagichi, T. Yamano, Wakayama Medical University, Wakayama, Japan
014
11:30 MYOCARDIAL STRAIN FOR THE ASSESSMENT OF LV FUNCTION (Invited Lecture)
S.F. Nagueh, Methodist DeBakey Heart and Vascular Center, Houston, TX, USA
015
11:45 MYOCARDIAL VIABILITY AND OUTCOMES IN ISCHEMIC CARDIOMYOPATHY (Invited Lecture)
J. Shirani, St. Luke’s Hospital and Health Network, Bethlehem, PA, USA
017
12:00 NOVEL USES OF CARDIAC MRI FOR NON-ISCHEMIC HEART DISEASE (Invited Lecture)
R.W.W. Biederman, Temple University School of Medicine, Carnegie Mellon University, Pittsburgh, PA, USA
018
12:15 NON-INVASIVE CARDIOVASCULAR IMAGING FOR EVALUATION OF CORONARY ARTERY BYPASS GRAFT DISEASE (Invited Lecture)
A. Elhendy, Marshfield Clinic, Marshfield, WI, USA
019
12:30 PROGNOSTIC VALUE OF STRESS ECHOCARDIOGRAPHY IN PATIENTS WITH CORONARY ARTERY DISEASE (Invited Lecture)
M. Prokudina, I. Konstantinov, P. Kozlov, P. Mochalov, E. Bobrova,
E. Karev, Federal Center of Heart, Blood and Endocrinology, St. Petersburg, Russia
020
12:45 OPTICAL COHERENCE TOMOGRAPHY (OCT): WHAT YOU NEED TO KNOW (Invited Lecture)
J.A. Garcia, Denver Health Medical Center (DHMC) and University of Colorado Hospital at Denver, Denver, CO, USA
021
13:00 LUNCH BREAK, VISIT POSTERS AND EXHIBITION  
SATURDAY, JULY 27, 2013
10:45 - 13:00   HALL C
  S21   Session:  
VALVULAR HEART DISEASE / CONGENITAL HEART DISEASE / PEDIATRIC CARDIOLOGY

Chairs:
D.H. Heistad, Iowa City, IA, USA
J. Ye, Vancouver, BC, Canada
 
10:45 VALVE PROSTHESIS-PATIENT MISMATCH (VP-PM): A LONG-TERM PERSPECTIVE
S.D. Daneshvar, S.H. Rahimtoola, University of Southern California, Los Angeles, CA, USA
022
11:00 COMPARISON OF DIFFERENT SURGICAL APPROACHES IN PATIENTS WITH TRANSPOSITION OF THE GREAT ARTERIES
C. Junge, M. Westhoff-Bleck, S. Schoof, F. Danne, S. Geyer, J.A. Seabrook, R Buchhorn, G. Ziemer, A. Wessel, K. Norozi, Western University, London, ON, Canada
023
11:15 DETERMINATION OF RECURRENT TACHYCARDIA FOLLOWING SUCCESSFUL ABLATION IN SUBJECTIVELY SYMPTOMATIC CHILDREN
P.P. Karpawich, D.P. Bhat, W. Du
The Children’s Hospital of Michigan, Wayne State University, Detroit, MI, USA
024
11:30 RELATION OF ECHOCARDIOGRAPHIC AORTIC VALVE SCLEROSIS TO VALVULAR CALCIFICATION ON MULTISLICE COMPUTED TOMOGRAPHY
L.H. Chebrolu, Y.R. Acharya, J. Shirani
St. Luke’s University Health Network, Bethlehem, PA, USA
025
11:45 ACQUIRED VON-WILLEBRAND DISEASE SECONDARY TO MITRAL AND AORTIC REGURGITATION
S.H .Wan, J.J. Liang, R. Vaidya, J.L. Blackshear, D. Chen
Mayo Clinic, Rochester, MN, USA
026
12:00 LEFT-RIGHT-LEFT, LEAD PLACEMENT ERRORS IN PEDIATRIC ELECTROCARDIOGRAPHY
J. Kleinman, E. Stockwell, J. Burrell, S. Darwin, C. Snyder, Case Western Reserve University School of Medicine, Cleveland, OH, USA
028
12:15 A SILENT PRESENTATION OF A SERIOUS ILLNESS: INFECTIVE ENDOCARDITIS
A. Hamadah, S. Sadaranagani, E. Berbari, Mayo Clinic, Rochester, MN, USA
029
12:30 ANY DEGREE OF MITRAL REGURGITATION FOUND DURING INVASIVE VENTRICULOGRAPHY IS ASSOCIATED WITH ALL CAUSE MORTALITY
M.R. Movahed, K. Lata, University of Arizona, Tucson, AZ, USA
030
12:45 PREDICTORS OF CARDIAC RELATED MORTALITY AFTER AVR FOR DEGENERATIVE AS IN NORMAL EJECTION FRACTION
H.M. Lee, P.Y. Park, Y.T. Lee, W.S. Kim, K. Sung, D.S. Jeong
Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea
031
13:00 LUNCH BREAK, VISIT POSTERS AND EXHIBITION  
SATURDAY, JULY 27, 2013
10:45 - 13:45   HALL D
  S22   Session:  
ASSESSMENT AND MANAGEMENT OF CARDIOVASCULAR RISK / MODIFICATION OF LIPOPROTEINS

Chairs:
E.A. Amsterdam, Sacramento, CA, USA
V. Regitz-Zagrosek, Berlin, Germany
 
10:45 GENDER DIFFERENCES IN ARTERIOTOMY CLOSURE AND TREATMENT FOR PERCUTANEOUS CORONARY INTERVENTIONS: RESULTS FROM A NATIONAL, MULTI-SITE CLINICAL REGISTRY OF 59,000 PATIENTS
D.R. Dobies, K.R Barber, A.L. Cohoon
Genesys Regional Medical Center, Grand Blanc, MI, USA
033
11:00 ADVANCED LIPID TESTING PREDICTS SUBCLINICAL ATHEROSCLEROSIS IN LOW RISK POPULATION BEYOND TRADITIONAL RISK FACTORS
P. Krishnamoorthy, D. Rader, M.P. Reilly, N.N. Mehta
Englewood Hospital and Medical Center, Englewood, NJ, USA
034
11:15 IMPACT OF CONTINUOUS POSITIVE AIRWAY PRESSURE THERAPY ON NON-HDL AND TOTAL CHOLESTEROL IN OSA PATIENTS
A. Kumar, A.A. Almomani, S. Pilli, R.K. Shah, A. Aljaafareh, S.K. Onguti, M. Alghrouz, W.I. Khalife, A.R. Al Emam, S. Jokhio
University of Texas Medical Branch, Galveston, TX, USA
035
11:30 PHYSICIAN-PROVIDED LIFESTYLE MODIFICATION COUNSELING FOR HYPERLIPIDEMIA – DOES IT HELP?
R.S. Loomba, S. Aggarwal, N. Gupta, S. Khosla, R.R. Arora
Children’s Hospital of Wisconsin, Wauwatosa, WI, USA
036
11:45 UTILITY OF AMBULATORY BP MONITORING IN A CARDIAC PREVENTION AND REHABILITATION PROGRAMME
M. Mahmood, S.B Connolly
Bangabandhu Sheikh Mujib Medical University, Bangladesh
 
037
12:00 ARTIFICIAL INTELLIGENCE MODEL OF CARDIOVASCULAR RISK IN RENAL DISEASE OUTLINES CAROTID MARKERS
O. Sandu, I. Nastac, J. Uribarri
Albert Einstein College of Medicine, NY; USA
 
038
12:15 PLANT STEROLS AND CARDIOVASCULAR DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS
B. Genser, G. Silbernagel, G. De Backer, E. Bruckert, R. Carmena, M.J. Chapman, J. Deanfield, O.S. Descamps, E.R. Rietzschel, W. Maerz
Medical Faculty Mannheim, University of Heidelberg, Heidelberg, Germany
 
039
12:30 COMPARISON OF CLINICAL CHARACTERISTICS, OUTCOME AND MORTALITY IN SYMPTOMATIC PATIENTS WITH AND WITHOUT LEFT BUNDLE BRANCH BLOCK
F.A. Alkindi , A.M Arabi, A.A. Patel, J. Alsuwaidi, A. Gehani , R. S Singh, H. Albinali
Hamad Medical Corporation, Doha, Qatar
 
040
12:45 BRAIN NATRIURETIC PEPTIDE AS A PREDICTOR OF ADVERSE CARDIAC EVENTS AFTER SUCCESSFUL PERCUTANEOUS CORONARY INTERVENTIONS IN PATIENTS WITH ACUTE CORONARY SYNDROME
Y.Y. Abdelmonem, S. Awni, A. Kaddah, Y. Yazeed, Kasr Alaini Medical School, Cairo, Egypt
 
041
13:00 USING CHADS2 SCORE TO IDENTIFY ELDERY PATIENTS WITH ATRIAL FIBRILLATION
M.H. Kwok, S. Punekar
University of Manchester, Manchester, UK
 
042
13:15 TRENDS IN CARDIOVASCULAR DISEASE IN ETHIOPIA: A 30-YEAR RETROSPECTIVE ANALYSIS OF MEDICAL-ICU ADMISSIONS
C. Smitson, A. Giday, S. Zaeh, E. Weldeyes, J. O’Mara
Yale University, New Haven, CT, USA
 
043
13:30 FENOFIBRATE THERAPY IN PATIENTS WITH HYPERTRIGLYCERIDEMIA HAS SUBSTANTIAL BENEFITS OVER OMEGA-3 FATTY ACIDS
K.K. Koh, Gachon University Gil Medical Center, Incheon, Korea
032
13:45 LUNCH BREAK, VISIT POSTERS AND EXHIBITION  
SATURDAY, JULY 27, 2013
14:00 - 16:00   HALL A
 

PL03   Plenary Session:
PREVENTION OF CARDIOVASCULAR DISEASE: ASSESSMENT AND MANAGEMENT OF CARDIOVASCULAR RISK
Joint Session with the American Society for Preventive Cardiology

Chairs:
S.L. Kopecky, Rochester, MN, USA
N.D. Wong, Irvine, CA, USA

 
14:00 SEX DIFFERENCES IN CARDIOVASCULAR DISEASE (Invited Lecture)
V. Regitz-Zagrosek, Center for Cardiovascular Research (CCR) Coordinator Berlin, German
 
079
14:15 THE ASSOCIATION BETWEEN DEPRESSION AND DIABETES (Invited Lecture)
E. Barrett-Connor, UCSD Dept. of Family and Preventive Medicine, La Jolla, CA, USA
080
14:30 ALDOSTERONE - A BRIDGE BETWEEN CARDIOVASCULAR AND MOOD DISORDERS? (Invited Lecture)
D. Jezova, N. Hlavacova, Slovak Academy of Sciences, Bratislava, Slovak Republic
081
14:45 HDL AND THE ATHEROSCLEROSIS - MYTH OR REALITY (Invited Lecture)
R.S. Rosenson, Mount Sinai Heart Mount Sinai School of Medicine, New York, NY, USA
082
15:00 OMEGA-3 SUPPLEMENTATION IMPROVES ARTERIAL STIFFNESS AND BIOMARKERS OF CV RISK IN LATINO AND WHITE PATIENTS WITH HYPERTENSION SERVED BY A SAFETY-NET HEALTHCARE SYSTEM (Invited Lecture)
C.S. Long, M.J. Krantz, University of Colorado Health Sciences Center and Denver Health Medical Center, Denver, CO, USA
083
15:15 USE OF NMR LDL LIPOPROTEIN PARTICLE ANALYSIS IN CARDIOVASCULAR DISEASE PREVENTION (Invited Lecture)
S.L. Kopecky, Mayo Clinic, Rochester, MN, USA
084
15:30 IMPACT OF RENAL SYMPATHETIC DENERVATION IN PATIENTS WITH DRUG RESISTANT HYPERTENSION (Invited Lecture)
K. Seidl, Klinikum Ingolstadt GmbH, Ingolstadt, Germany
085
15:45 BEYOND HDL CHOLESTEROL: WHAT CAN WE LEARN FROM HDL PARTICLE NUMBER AND SIZE?
S. Mora, Brigham and Women’s Hospital, Boston, MA, USA
             
087
16:00 COFFEE BREAK, VISIT POSTERS & EXHIBITION  
SATURDAY, JULY 27, 2013
14:00 - 16:15   HALL B
  PL04   Plenary Session:
SUDDEN CARDIAC DEATH / ADVANCES IN IMPLANTABLE RHYTHM DEVICE THERAPY

Chairs:
M.E. Cain, Buffalo, NY, USA
A.B. Curtis, Buffalo, NY, USA
 
14:00 IMPACT OF DENERVATED MYOCARDIUM ON IMPROVING RISK STRATIFICATION FOR SUDDEN CARDIAC DEATH (Invited Lecture)
M.E. Cain, University at Buffalo, Buffalo, NY, USA
088
14:15

THE ROLE OF ELECTROPHYSIOLOGIC TESTING ON OUTCOME IN PATIENTS WITH ARVC (Invited Lecture)
F. Duru, University Hospital of Zurich, Switzerland
 

090
14:30 ROBOTICS IN THE EP LABORATORY: PROMISE, REALITY AND FUTURE DIRECTIONS (Invited Lecture)
E. Gang, David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
091
14:45

BIVENTRICULAR PACING FOR ATRIOVENTRICULAR BLOCK AND SYSTOLIC DYSFUNCTION (Invited Lecture)
A.B. Curtis, S.J. Worley, P.B. Adamson, E.S. Chung, I. Niazi, L. Sherfesee, T. Shinn, M. St. John Sutton, University of Buffalo, NY, USA

092
15:00 IN THE OR V. THE EP LAB--WHERE IS THE BEST LOCATION FOR LEAD EXTRACTION (Invited Lecture)
C.A. Henrikson, Oregon Health & Science University, Portland, OR, USA
094
15:15 CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA: THE CLINICIAN’S PERSPECTIVE (Invited Lecture)
M.J. LaPage, University of Michigan, Ann Arbor, MI, USA
095
15:30

GENETIC BACKGROUND, CLINICAL CHARACTERISTICS, AND TREATMENT OF EARLY REPOLARIZATION SYNDROME (Invited Lecture)
H. Watanabe, Niigata University Graduate School of Medical & Dental, Asahimachidori, Japan

096
15:45 THE EVOLUTION OF THE PACING SITE: PAST, PRESENT AND FUTURE (Invited Lecture)
Y. Oginosawa, University of Occupational and Environmental Health, Yahatanishi, Kitakyushu, Japan
097
16:00 A BLOOD TEST TO PREDICT ARRHYTHMIC RISK
G. Gao, V. Brahmanandam, M. Raicu, L. Gu, A. Shah, S. Negi, M. Wood, A Tatooles, A. Schwartz, S.C. Dudley
University of Illinois at Chicago, and the Jesse Brown VAMC, Chicago, Illinois, USA
098
16:15 COFFEE BREAK, VISIT POSTERS & EXHIBITION  
SATURDAY, JULY 27, 2013
14:00 - 16:00   HALL C
  S23  Session:
NEW DIRECTIONS IN CARDIAC SURGERY: SURGICAL REVASCULARIZATION / MECHANICAL CIRCULATORY SUPPORT / CARDIAC TRANSPLANTATION

Chair:
M.R. Johnson, Madison, WI, USA

 
14:00 HOSPITAL READMISSIONS IN OUTPATIENTS SUPPORTED WITH CONTINUOUS FLOW LEFT VENTRICULAR ASSIST DEVICES
D. Zhang, J. Shuster, H. Craddock, N. Huelsmann, S. Silvestry, S. Joseph, Barnes Jewish Hospital/Washington University School of Medicine, Saint Louis, MO, USA
099
14:15 MULTIPLE ARTERIAL GRAFTS IMPROVE LATE SURVIVAL OF PATIENTS UNDERGOING CORONARY ARTERY BYPASS GRAFTING
C. Leker Locker, H.V. Schaff, J.A. Dearani, L.D. Joyce, S.J. Park,
H.M. Burkhart, R.M. Suri, K.L. Greason, J.M. Stulak, R.C. Daly
Mayo Clinic, Rochester, MN, USA
100
14:30 PREDICTORS OF ACUTE CELLULAR REJECTION AND ITS ASSOCIATION WITH CARDIAC ALLOGRAFT VASCULOPATHY IN HEART TRANSPLANT PATIENTS
W.I Khalife, R.P. Vivo, S. Garikipati, P. Nalabothu, S. Johnson, K. Kislingbury, R. Sharif, A. Charif
University of Texas Medical Branch, Galveston, TX, USA
101
14:45 REDUCTION IN LV SIZE AFTER LVAD IMPLANTATION IS ASSOCIATED WITH REDUCTION IN QRS VOLTAGE AND DURATION
M.G. Sendra Ferrer, J.E. Banchs, T. Moukabary, S. Ferns, E.D. Penny-Peterson, S.M. Samii, D.L. Wolbrette, G.V. Naccarelli, M.D. Gonzalez, Pennsylvania State University, Hershey, PA, USA

102
15:00 CUSTODIOL-N VERSUS CUSTODIOL: A PROSPECTIVE RANDOMIZED DOUBLE BLIND MULTICENTER PHASE III TRIAL
G. Szabo, A. Weymann, B. Schmack, D. Badowski, G. Veres, M. Karck
University of Heidelberg, Heidelberg, Germany
104
15:15 LOW INCOME IS AN INDEPENDENT PREDICTOR OF IN-HOSPITAL MORTALITY AMONG HEART TRANSPLANT RECIPIENTS: A NATIONWIDE INPATIENT SAMPLE STUDY
A. Rab, M. Mujib, S. Khera, D. Kolte, C. Palaniswamy, W.S. Aronow
Stony Brook University, Stony Brook, NY, USA
105
15:30 IMPACT OF POSTTRANSPLANT WEIGHT GAIN ON CARDIAC ALLOGRAFT VASCULOPATHY
G. Hoefle, C.H. Saely, M. Martinelli, B. Meier, T. Carrel, M. Seitz,
P.M. Villiger, P. Mohacsi, Inselspital, Bern, Switzerland
106
15:45 SUCCESSFUL USE OF IMPELLA 2.5 DEVICE IN CARDIAC ARREST DUE TO LEFT MAIN STENOSIS
M.A Zulqarnain, N. Nagajothi, Canton Medical Education Foundation, Canton, OH, USA
107
16:00 COFFEE BREAK, VISIT POSTERS & EXHIBITION  
SATURDAY, JULY 27, 2013
14:00 - 16:45   HALL D
  S24  Session:
MOLECULAR CARDIOLOGY, BASIC RESEARCH

Chairs:
J.G. Filep, Montreal, QC, Canada
K.N. Pandey, New Orleans, LA, US
 
14:00 THE ROLE OF GALECTIN-3 AND CONNECTIVE TISSUE GROWTH FACTORS IN HYPERTENSIVE PATIENTS WITH DIASTOLIC HEART FAILURE: LINK OF CLINICAL AND BASIC STUDIES
J-J Chen, W-R Hao, C-K Wu, K-C Chang, J-C Liu, C-T Tsai
China Medical University, Taichung, Taiwan
108
14:15 CARDIOMYOCYTE-CARDIAC FIBROBLAST INTERACTION IN THE PATHOGENESIS OF DIABETIC CARDIOMYOPATHY - ROLE OF HMGB1/TLR4/IL-33 AXIS
X.M. Xu, J.C. Zhang, H. Xu, R. Kao, C.M. Martin, T. Rui
Lawson Health Research Institute, London, ON, Canada
109
14:30 DOXORUBICIN-INDUCED CARDIOTOXICITY IN MICE IS PREVENTED BY LATE INA INHIBITION WITH RANOLAZINE, WITH IMPROVEMENT IN HEART FUNCTION, FIBROSIS AND APOPTOSIS
C. Coppola, G. Piscopo, C. Cipresso, D. Rea, C. Maurea, E. Esposito, C.G. Tocchetti, C. De Lorenzo, C. Arra, N. Maurea
National Cancer Institute Pascale Foundation, Naples, Italy
110
14:45 ATORVASTATIN INDUCES AUTOPHAGY OF MESENCHYMAL STEM CELLS UNDER HYPOXIA AND SERUM DEPRIVATION VIA MEK/ERK PATHWAY
N. Li, Q. Zhang, C. Jin, H.Y. Qian, Q.T. Dong, H. Xu, H. Zhang, Y.J. Yang
Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China
111
15:00 EXCITABILITY OF DIRECT REPROGRAMMED MURINE TAIL FIBROBLASTS: BETWEEN WILD-TYPE FIBROBLASTS AND CARDIOMYOCYTES
M. Rav Acha, R.Mills, J.X. Chen, S.M. Wu, D. Milan
Massachusetts General Hospital, Charlestown, MA, USA
112
15:15 IMPORTANCE OF SLMAP IN CARDIOMYOCYTE VIABILITY AND MEMBRANE FUNCTION
A. Mahmood, M. Salih, B.S. Tuana
University of Ottawa, Ottawa, ON, Canada
113
15:30 GLIVEC (IMATINIB MESYLATE) INDUCES AUTOPHAGIC SIGNALLING IN CARDIAC MYOCYTES
L.P. Grazette, R. Kerkela, T. Force, A. Rosenzweig
Keck Medical Center of USC, Los Angeles, CA, USA
114
15:45 CARDIOMYOCYTE-SECRETED ACETYLCHOLINE IS REQUIRED FOR MAINTENANCE OF HOMEOSTASIS IN THE HEART
A. Roy, W.C. Fields, C. Rocha-Resende, R.R. Resende, S. Guatimosim, V.F. Prado, R. Gros, M.A. Prado
Robarts Research Institute, London, Ontario, and
The University of Western Ontario, London, Canada
115
16:00 UTILITY OF 2D-SPECKLE TRACKING ECHOCARDIOGRAPHY IN DIAGNOSIS OF LEFT VENTRICULAR DYSFUNCTION IN ANTI-ERBB2 THERAPY
C. Coppola, G. Piscopo, C. Cipresso, D. Rea, C. Maurea,
C. Quintavalle, C.G. Tocchetti, G. Condorelli, C. Arra, N. Maurea
National Cancer Institute Pascale Foundation, Naples, Italy
116
16:15 HMG-COA REDUCTASE INHIBITORS IMPAIR SURVIVAL OF HUMAN MESENCHYMAL STEM CELLS VIA NF-B SIGNALING
A.L. Muller, Y. Li, M.A. Ngo, K. Sran, R.C. Arora, L.A. Kirshenbaum, D.H. Freed
St. Boniface Research Centre; University of Manitoba, Winnipeg, Canada
117
16:30 TETRAHYDROBIOPTERIN DEFICIENCY INDUCED HEART FAILURE VIA DYSREGULATION OF MITOCHONDRIAL BIOGENESIS, OXIDATIVE PHOSPHORYLATION AND ANTIOXIDANT SYSTEM
H.K. Kim, I-S. Song. N. Kim, K.S. Ko, B.D. Rhee, J. Han
Cardiovascular and Metabolic Disease Center, Inje University, Busan, Korea
118
SATURDAY, JULY 27, 2013
16:45-19:15   HALL A
  PL05   Plenary Session:
INFLAMMATION / INNATE AND ADOPTIVE IMMUNITY AND CARDIOVASCULAR DISEASES
Joint Session with the American College of Cardiology / California Chapter

Chairs:
M. Navab, Los Angeles, CA, USA
R. Roberts, Ottawa, ON, Canada
 
16:45 INFLAMMATION - THE NEW TARGET FOR PREVENTION OF CORONARY ARTERY DISEASE (Invited Lecture)
R. Roberts, University of Ottawa Heart Institute, Ottawa, ON, Canada
119
17:00 SEPSIS AND THE CARDIOVASCULAR SYSTEM: GOING TO THE HEART OF THE MATTER (Invited Lecture)
M.A. Rossi, L.M Malvestio, M.R. Celes, V. Blefari, C.M. Prado,
M.J. Figueiredo, University of Sao Paulo. Brazil
120
17:15 NEUTROPHILS IN ACUTE CORONARY ARTERY DISEASE (Invited Lecture)
J.G. Filep, Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada
121
17:30 INTERACTION OF GENE AND SALT DIETS ON CARDIAC ANGIOTENSIN II, ALDOSTERONE, AND CYTOKINES IN HYPERTROPHIED HEART (Invited Lecture)
K.N. Pandey, Tulane University School of Medicine, New Orleans, LA, USA
122
17:45 MICROBIOTA, SYSTEMIC INFLAMMATION AND CARDIOVASCULAR FUNCTION (Invited Lecture)
M. Navab, S. Safar, G. Hough, F. Sedigh, A. Gapeleh, A. Ordookhani,
Z. Barseghyan, R. Aliali, S. Reddy
David Geffen School of Medicine at UCLA, Los Angeles, CA, USA
123
18:00 ROLE OF COPPER TRANSPORTERS IN VASCULAR REMODELING AND INFLAMMATION (Invited Lecture)
T. Fukai, University of Illinois at Chicago, Chicago, IL, USA
124
18:15 THE COMPLEX CARDIOVASCULAR EFFECTS OF LEPTIN (Invited Lecture)
M.A. Allison, University of California, San Diego, La Jolla, CA, USA
125
18:30 HUMAN ENTEROVIRUS PERSISTENCE: POTENTIAL FOR EXACERBATION OF MYOCARDITIS (Invited Lecture)
N.M. Chapman, S. Tracy
University of Nebraska Medical Center, Omaha, NE, USA
126
18:45 CYTOKINES AND THE ROLE OF IMMUNOMODULATION IN HEART FAILURE OF DIFFERENT ETIOLOGIES (Invited Lecture)
D. Anzulovi-Miroševi, L Barzon, I Castagliuolo, P. Brun, G. Palù, M. Zaninotto, M. Maria Mion, M. Plebani, S. Dalla-Volta
University of Padua Medical School, Padua; Italy
495
19:00 VIRAL ANTI-ATHEROGENIC PROTEINS ALTER MONOCYTE AND NEUTROPHIL INVASION IN MICE WITH ALTERED BAG3 GENE EXPRESSION
J. Davids, S. Saikaly, A.R. Lucas
Cardiovascular Medicine, University of Florida, Gainesville, FL, USA
127
SATURDAY, JULY 27, 2013
16:45 - 19:15   HALL B
  PL06   Plenary Session:
ADVANCES IN CARDIOVASCULAR SURGERY / CAROTID AND CORONARY REVASCULARIZATION / HEART TRANSPLANTATION

Chairs:
S. Bertog, USA
D.M. Meyer
, Dallas, TX, USA

 
16:45 NEW STRATEGIES FOR ACUTE STROKE INTERVENTION (Invited Lecture)
H. Sievert, L. Vaskelyte, I. Hofmann, J. Franke, S. Gafoor, S. Lam,
S. Bertog, CardioVascular Center Frankfurt, Frankfurt, Germany
128
17:00 CHANGES IN HEART ALLOCATION FOR TRANSPLANTATION IN THE US AND WORLDWIDE: OPTIONS FOR A BETTER SOLUTION (Invited Lecture)
D.M. Meyer, University of Texas Southwestern, Med Center at Dallas, Dallas, TX, USA
129
17:15 SIMULTANEOUS HEART-KIDNEY TRANSPLANTATION (Invited Lecture)
M.R. Johnson, University of Wisconsin-Madison, Madison, WI, USA
131
17:30 UPDATE ON THE TREATMENT OF LEFT MAIN DISEASE (Invited Lecture)
B.F. Uretsky, University of Arkansas for Medical Sciences, Little Rock, AR, USA
132
17:45 CALIFORNIA REVASCULARIZATION: PCI OUTCOMES IN THE SUNSHINE STATE (Invited Lecture)
S. Ram, T.G. Patel, L. Vazquez, Z. Li, PCI-CAMPOS Investigators,
W.J. Bommer
University of California Davis, Medical Center, Davis, CA, USA
133
18:00 UPDATE ON THE USE OF IMPELLA ASSIST DEVICE FOR HIGH RISK PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTIONS (Invited Lecture)
M.R. Movahed, University of Arizona Sarver Heart Center, Tucson, AZ, USA
134
18:15 DEVICE CLOSURE OF ASD- LONG-TERM FOLLOW UP WITH SPECIAL REFERENCE TO COMPLICATIONS (Invited Lecture)
M. Sadiq, The Childrens Hospital, Punjab Institute of Cardiology, Lahore, Pakistan
135
18:30 WHERE IS THE FINE BALANCE BETWEEN IMMUNOSUPPRESSION AND MALIGNANCY IN CARDIAC TRANSPLANTATION? (Invited Lecture)
N. Nair, Texas A&M HSC College of Medicine, Temple, TX, USA
136
18:45 MANAGEMENT STRATEGIES OF COMBINED SEVERE SYMPTOMATIC CAROTID AND CORONARY ARTERY DISEASE (Invited Lecture)
M. Abu-Fadel, University of Oklahoma HScC, Oklahoma City, OK, USA
137
19:00 THE NO-TOUCH SAPHENOUS VEIN AS THE PREFERRED SECOND CONDUIT FOR CORONARY ARTERY BYPASS SURGERY
M. Dreifaldt, J.D. Mannion, L. Bodin, H. Olsson, L. Zagozdzon, D. Souza University Hospital, Orebro, Sweden
138
SATURDAY, JULY 27, 2013
16:45 - 18:45   HALL C
  S25  Session:
SYSTEMIC AND PULMONARY HYPERTENSION, BASIC AND CLINICAL

Chairs:
Y. Charuzi, Los Angeles, CA, USA
K. Seidl, Ingolstadt, Germany
 
16:45 INGESTION-TIME-DEPENDENT EFFECTS OF HYPERTENSION TREATMENT ON AMBULATORY BLOOD PRESSURE IN PATIENTS WITH CHRONIC KIDNEY DISEASE: THE HYGIA PROJECT
D.E. Ayala, M.T. Rios, J.J. Crespo, E. Sineiro, A. Moya, A. Otero, M. Dominguez, A. Mojon, J.R. Fernandez, R.C. Hermida
University of Vigo, Vigo, Spain
139
17:00 RENAL SYMPATHETHIC DENERVATION FOR RESISTANT HYPERTENSION IN THE REAL WORLD CLINICAL PRACTICE: PRELIMINARY RESULTS OF THE SYMPLICITY VENEZUELA REGISTRY
H.S. Casal, C. Collet, B. Burger, N. Beer, G. Varnagy, M. Herrera,
I. Mendoza, J. Munoz, C. Calderas, R. Lopez
Hospital de Clinicas Caracas, Venezuela
140
17:15 PREVALENCE OF HYPERTENSION IS HIGHER IN WOMEN WITH AN EXPERIENCE OF PRE-ECLAMPSIA
M.S. Shin, B.R. Kim, S.J. Park, S.W. Han, I.M. Chung, D.J. Choi,
M.C. Cho, Gachon University Gil Hospital, Incheon, Korea
141
17:30 PROGNOSTIC VALUE FOR CARDIOVASCULAR RISK OF CLINIC AND AMBULATORY BLOOD PRESSURE IN CHRONIC KIDNEY DISEASE
R.C Hermida, D.E. Ayala, A. Mojon, J.R. Fernandez
University of Vigo, Vigo, Spain
142
17:45 PREVALENCE OF HYPERTENSION AND ITS ASSOCIATION WITH METABOLIC RISK FACTORS IN TYPE 2 DIABETIC PUNJABI POPULATION
R. Kapoor, R. Duggal, S. Kapoor, R. Kapoor
Carewell Heart & Superspeciality Hospital, Amritsar, Punjab, India
143
18:00 CARDIORESPIRATORY RESPONSE TO EXERCISE AFTER RENAL SYMPATHETIC DENERVATION IN RESISTANT HYPERTENSION
C. Ukena, F. Mahfoud, S. Ewen, I. Kindermann, M. Boehm
Innere Medizin III - Universitaetsklinikum des Saarlandes, Homburg/Saar, Germany
144
18:15 CORRELATION BETWEEN LVEDP AND PCWP IN PATIENTS WITH PULMONARY HYPERTENSION
W.I. Khalife, M. Morsy, T. Abu Sharifeh, UTMB, Galveston, Texas, USA
145
18:30 PREDICTORS OF PULMONARY HYPERTENSION IN PATIENTS WITH DIASTOLIC DYSFUNCTION
P. Rodriguez-Lozano, W.I. Khalife, M. Morsy, S. Mutnuri, A. Khan, J. Rodriguez
UTMB, Galveston, TX, USA
146

 

Saturday,
July 27, 2013
Sunday,
July 28, 2013
Monday,
July 29, 2013
Oral Presentations Oral Presentations Oral Presentations
Poster Sessions Poster Sessions Poster Sessions

News

Reduced Registration Deadline:
July 15, 2013

Final Program now online. new

The scientific program of the 18th World Congress on Heart Disease has been reviewed by the American Medical Association and approved for a maximum of 25.75 AMA PRA Category 1 Credits™.

Publication of Abstracts: new
Abstracts were published in a special online only supplement issue of the journal CARDIOLOGY.
Click here to view.

 

 

. toronto


Affiliated with

 

    international academy of cardiology

Endorsed by